FDA Inspection 1237719 — Willow Birch Pharma, LLC

Willow Birch Pharma, LLC — FEI 3009864247

The FDA completed an inspection of Willow Birch Pharma, LLC on May 3, 2024 in Taylor, MS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 3, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taylor, MS (United States)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records